Skip to main content

CORRECTION article

Front. Immunol., 22 March 2021
Sec. Immunological Tolerance and Regulation

Corrigendum: Generation of Powerful Human Tolerogenic Dendritic Cells by Lentiviral-Mediated IL-10 Gene Transfer

  • San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), San Raffaele Scientific Institute (IRCCS), Milan, Italy

A Corrigendum on
Generation of Powerful Human Tolerogenic Dendritic Cells by Lentiviral-Mediated IL-10 Gene Transfer

By Comi M, Amodio G, Passeri L, Fortunato M, Santoni de Sio FR, Andolfi G, Kajaste-Rudnitski A, Russo F, Cesana L and Gregori S (2020). Front. Immunol. 11:1260. doi: .10.3389/fimmu.2020.01260

In the original article, there was a mistake: a duplication of one dot plot in Figure 8B as published. The corrected Figure 8 appears below.

FIGURE 8
www.frontiersin.org

Figure 8 In vitro characterization of murine DCIL-10. Female Balb/c BM cells were differentiated into DC, transduced at day 2 with LV-GFP (DCGFP) or LV-IL-10 (DCIL-10), and activated with LPS (200 ng/ml) during the last 2 days of differentiation. (A) Transduction efficiency was quantified based on ∆NGFR expression and the expression of the indicated markers was analyzed at day 9 of differentiation by flow cytometry. Each dot represents a single experiment (n = 8-9), lines indicate median, while whiskers are minimum and maximum levels. (B) DC were plated and left unstimulated or stimulated with LPS (200 ng/ml) for 24 h, with the addition of brefeldin A at 6 h. The expression of human IL-10 was quantified by intracytoplasmic staining. One representative donor out of two is depicted, and percentages of positive cells are indicated. (C) Spleen cells from female C57Bl/6 mice were stained with a proliferation dye and stimulated with Balb/c DCGFP and DCIL-10 at 1:10 ratio. At day 5, proliferation of CD4+ and CD8+ T cells was measured by flow cytometry. Each dot represents a single donor (n = 6), lines indicate median, while whiskers are minimum and maximum levels. *P ≤ 0.05 (Wilcoxon matched pairs test, two-tailed).

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: dendritic cells, IL-10, cell therapy, immune tolerance, allogeneic transplantation

Citation: Comi M, Amodio G, Passeri L, Fortunato M, Santoni de Sio FR, Andolfi G, Kajaste-Rudnitski A, Russo F, Cesana L and Gregori S (2021) Corrigendum: Generation of Powerful Human Tolerogenic Dendritic Cells by Lentiviral-Mediated IL-10 Gene Transfer. Front. Immunol. 12:672701. doi: 10.3389/fimmu.2021.672701

Received: 26 February 2021; Accepted: 08 March 2021;
Published: 22 March 2021.

Copyright © 2021 Comi, Amodio, Passeri, Fortunato, Santoni de Sio, Andolfi, Kajaste-Rudnitski, Russo, Cesana and Gregori. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Silvia Gregori, gregori.silvia@hsr.it

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.